Frontierby eninvs

Language: EN · RU

← Region

Promomed USD

Update

Re-runs extraction for each period with period-end year from max(2023, current year − 2) through the current year, oldest first (up to three reporting years). This can take a long time.

Sector: Healthcare

RU_PRMD

Price chart

392.8 RUBDay -0.82%

Key metrics

Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.

Market

Price
392.8 RUB · -0.82%
Market cap
1.2 bn USD

Growth

Δ revenue y/y
71.8%
Δ EBITDA y/y
84.2%

Multiples

P/E (LTM)
19.5x
P/B (FY)
4.2x
EV/EBITDA (LTM)
EV/EBITDA (ann.)
77.6x

Cash return

Dividend yield
FCF yield (LTM)

Liquidity

Daily turnover (MOEX)
64.1 mln RUB

Shares: connector/market_inputs

Amounts: USD (converted) · As reported
Converted modes use NBK / ECB-linked rates: balance sheet date for BS items, period average for P&L and cash flow (see filing row evidence). As reported keeps each row in its filing currency.

🔍 Sanity check — subtotal consistency (Level-1 + Level-2) OK: 3 / Warn: 2 / Err: 9 / Autofix applied: 0
Port of PHP subtotal-total + sign-flip detection logic
PeriodIssues
2023-03-31 Q1Errors 1Warn 3
2023-06-30 Q2Warn 2
2023-09-30 Q3Errors 1
2023-12-31 FYErrors 1
2023-12-31 Q4Errors 1
2024-03-31 Q1Errors 3Warn 4
2024-06-30 Q2Errors 1Warn 1
2024-09-30 Q3OK
2024-12-31 FYWarn 1
2024-12-31 Q4Errors 1Warn 1
2025-03-31 Q1Errors 3
2025-06-30 Q2Errors 2Warn 1
2025-09-30 Q3OK
2025-12-31 Q4OK
All checks pass · Has warnings (review) · Has errors (needs fix) · ✓* Autofix applied (see evidence)

Financial dynamics

Monetary columns are in M USD, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.

DatePeriodStatusRevenueM USDOperating profitM USDD&AM USDEBITDAM USDNet profitM USDOperating CFM USDCapex + M&AM USDAssetsM USDEquityM USDROE (annualized)Net debtM USDSource
2025-12-31Q4 2025 (3M)PARTIAL172.5
y/y
y/y
y/y
76.8
y/y
y/y
y/y
y/y
22665.0
2025-09-30Q3 2025 (3M)PARTIAL81.5
y/y 71.8%
y/y
y/y
47.9
y/y 84.2%
y/y
y/y
y/y
21812.0
2025-06-30Q2 2025 (3M)OK91.0
y/y 37.4%
24.4
y/y 12.1%
4.6
y/y 25.7%
29.0
y/y 14.0%
9.9
y/y 58.5%
-5.2-10.9805.6
y/y 48.7%
294.9
y/y 75.0%
20957.7
2025-03-31Q1 2025 (3M)PARTIAL91.0
y/y 169.1%
24.4
y/y 5185.0%
4.6
y/y 45.1%
29.0
y/y 985.8%
9.9
y/y 260.3%
-5.2-10.9
y/y
y/y
19038.0
2024-12-31FY 2024 (12M)OK100.4
y/y 30.7%
37.7
y/y 22.8%
4.0
y/y -34.8%
41.7
y/y 13.2%
20.1
y/y 14.6%
11.0-32.2744.8
y/y 52.5%
275.6
y/y 51.1%
17117.7
2024-09-30Q3 2024 (3M)PARTIAL100.4
y/y 58.3%
37.7
y/y 22.8%
4.0
y/y 89.2%
41.7
y/y 27.1%
20.1
y/y 14.6%
11.0-32.2
y/y
y/y
17536.0
2024-06-30Q2 2024 (3M)OK66.2
y/y 32.5%
21.8
y/y 25.6%
3.6
y/y 24.9%
25.4
y/y 25.5%
6.3
y/y -40.7%
-8.1-11.3541.6
y/y 10.9%
168.5
y/y -7.6%
15.1%17954.5
2024-03-31Q1 2024 (3M)OK33.8
y/y 5.8%
-0.5
y/y -110.5%
3.1
y/y 31.1%
2.7
y/y 22.8%
-6.2
y/y -52.9%
-12.5-8.6491.7
y/y 0.7%
163.2
y/y -10.5%
-14.4%17515.4
2023-12-31FY 2023 (12M)OK76.8
y/y
30.7
y/y
6.1
y/y
36.8
y/y
17.6
y/y
-10.7-15.8488.4
y/y
182.4
y/y
16056.4
2023-09-30Q3 2023 (3M)PARTIAL63.4
y/y
30.7
y/y
2.1
y/y
32.8
y/y
17.6
y/y
-10.7-15.8
y/y
y/y
13985.0
2023-06-30Q2 2023 (3M)OK50.0
y/y
17.3
y/y
2.9
y/y
20.2
y/y
10.6
y/y
-2.4-23.6488.4
y/y
182.4
y/y
23.2%12352.0
2023-03-31Q1 2023 (3M)OK32.0
y/y
-0.2
y/y
2.4
y/y
2.2
y/y
-4.1
y/y
7.1-11.8488.4
y/y
182.4
y/y
10719.0
Data quality — review suggested

Revenue & EBITDA

RevenueEBITDA

Quarterly values ($ mln)

0501001502023 q32023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q4

Year-over-year change

0%250%500%750%1000%2023 q32023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q4

Cash flow

Net debt / cash ($ mln)

05 00010 00015 00020 00025 0002023 q32023 q42024 q12024 q22024 q32024 q42025 q12025 q22025 q32025 q4

Dividends

No dividend rows found for this issuer.

Reporting forms detected in loaded periods: (Balance sheet / Profit or loss (P&L) / Cash flows)